BROMOCRIPTINE AND ENDOCRINE DISORDERS

被引:37
作者
SPARK, RF
DICKSTEIN, G
机构
[1] BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02215 USA
[2] BETH ISRAEL HOSP, THORNDIKE LAB, BOSTON, MA 02215 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.7326/0003-4819-90-6-949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bromocriptine, a dopaminergic agonist, has been used to treat many endocrine disorders. In hyperprolactinemia associated with galactorrhea, amenorrhea, oligospermia, and impotence, bromocriptine reduces prolactin levels to normal and allows for satisfactory return of sexual and reproductive function in 90% of patients. In acromegaly, bromocriptine brings about subjective improvement in 75% of patients with reduction in growth-hormone levels to normal in 22% of patients. Bromocriptine has been used in premenstrual tension, functional infertility, Nelson's syndrome, and Cushing's disease with variable benefit. In low doses, side-effects are minimal. In higher doses, digital vasospasm and gastrointestinal bleeding have occurred. Although bromocriptine has been used in a wide variety of endocrine disorders, it appears to be most useful in treatment of male and female infertility associated with hyperprolactinemia.
引用
收藏
页码:949 / 956
页数:8
相关论文
共 56 条
[1]   EFFECT OF BROMOCRIPTINE ON PREMENSTRUAL SYNDROME - DOUBLE-BLIND CLINICAL-TRIAL [J].
ANDERSEN, AN ;
LARSEN, JF ;
STEENSTRUP, OR ;
SVENDSTRUP, B ;
NIELSEN, J .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1977, 84 (05) :370-374
[2]  
[Anonymous], FRONT NEUROENDOCRIN
[3]  
BENEDEKJASZMANN LJ, 1976, LANCET, V1, P1095
[4]  
BENJONATHAN N, 1976, FED PROC, V35, P305
[5]   EFFECTS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE AND BROMOCRYPTINE (CB-154) IN STATES OF ABNORMAL PITUITARY-ADRENAL-FUNCTION [J].
BENKER, G ;
HACKENBERG, K ;
HAMBURGER, B ;
REINWEIN, D .
CLINICAL ENDOCRINOLOGY, 1976, 5 (02) :187-190
[6]   GROWTH-HORMONE RELEASE INHIBITING HORMONE IN ACROMEGALY [J].
BESSER, GM ;
MORTIMER, CH ;
CARR, D ;
SCHALLY, AV ;
COY, DH ;
EVERED, D ;
KASTIN, AJ ;
TUNBRIDGE, WM ;
THORNER, MO ;
HALL, R .
BMJ-BRITISH MEDICAL JOURNAL, 1974, 1 (5904) :352-355
[7]   GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE [J].
BESSER, GM ;
MCNEILLY, AS ;
EDWARDS, CRW ;
PARKE, L ;
FORSYTH, IA .
BRITISH MEDICAL JOURNAL, 1972, 3 (5828) :669-&
[8]  
BOYAR RM, 1976, NEW ENGL J MED, V294, P905
[9]   STIMULATION OF HUMAN-GROWTH-HORMONE SECRETION BY L-DOPA [J].
BOYD, AE ;
LEBOVITZ, HE ;
PFEIFFER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (26) :1425-&
[10]   CHANGES IN PLASMA GROWTH-HORMONE LEVELS IN NORMAL AND ACROMEGALIC SUBJECTS FOLLOWING ADMINISTRATION OF 2-BROMO-ALPHA-ERGOCRYPTINE [J].
CAMANNI, F ;
MASSARA, F ;
BELFORTE, L ;
MOLINATTI, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (03) :363-366